Tumor deposits are a significant prognostic factor in colorectal cancer, yet underutilized in N-staging. Ten novel models incorporating tumor deposits showed improved prognostic performance over the ...
Moderate-to-severe traumatic brain injury (TBI), but not mild TBI, is associated with a significantly higher risk for malignant brain tumor, a new study showed. In a cohort that included more than 150 ...
Objective To evaluate if patients with laryngeal SCC homolateral cN+ and contralateral cN− should be submitted to bilateral neck dissection. Methods The team reviewed medical records from 135 patients ...
Prostate cancer has four stages, which describe how advanced the cancer is and how far it has spread throughout your body. Knowing the stage of your cancer can help you and your healthcare team ...
Oropharyngeal cancer is the most common type of throat cancer. After your diagnosis, you will learn the stage of the cancer. The stage lets you know how far, if at all, the cancer has spread from the ...
Background Recent studies showed an increase in neuroendocrine neoplasms, especially for the digestive tract. Several risk factors have been suggested to explain this increase, including a family ...
Background: Examined lymph node (ELN) count is a critical factor affecting the number of metastatic lymph nodes (MLNs). The impact of the ELN number on survival and staging remains unclear. Methods: ...
Objectives: Accurate determination of gastrointestinal tumor malignancy is a crucial focus of clinical research. Constructing coagulation index models using big data is feasible to achieve this goal.
ABSTRACT: Introduction: Vulva cancer is an uncommon disease. It represents about 3% to 5% of gynecologic cancers worldwide, but its incidence is increasing with age and Human Papilloma Virus (HPV) and ...
The new Sassun-Mayo staging system, which integrates tumor deposit and lymph node counts, improves prognostic accuracy for patients with colon cancer compared with the standard American Joint ...
Speaking at Hospital Healthcare Europe’s recent Clinical Excellence in Respiratory Care event, Dr Zaheer Mangera shared insights into the evolution of the neoadjuvant lung cancer pathway, its benefits ...